Business
Press Release Dec 15 2025
Zydus Lifesciences Limited has informed the Exchange regarding a press release dated December 15, 2025, titled "Sentynl Therapeutics Announces FDA Acceptance of CUTX-101 NDA Resubmission".
About this update from Zydus Lifesciences Limited
[{"type":"text","content":" Zydus Lifesciences Limited has informed the Exchange regarding a press release dated December 15, 2025, titled \"Sentynl Therapeutics Announces FDA Acceptance of CUTX-101 NDA Resubmission\". View Attachment","length":331,"tagName":"div"}]